Medical Center And Dispensaries Based Reporting

Objectives	- To enhance reporting from the ambulatory health system - To monitor communicable diseases by time, place and person - To detect alerts and outbreaks at local level
Sources of data	- Medical centers and dispensaries of the Ministry of Public Healht MOPH - Medical centers and dispensaries of the Ministry of Social Affairs MOSA - Other governemental medical centers and dispensaries - Medical centers and dispensaries of various Non-Governemetal Organizations NGO - Field medical units
Target diseases and syndromes	- Vaccine preventable diseases: acute flaccid paralysis, measles, rubella, pertussis (whooping cough) and mumps - For other communicable diseases: acute diarrhea, bloody/dysenteric diarrhea, cholera, acute jaundice, acute respiratory infection (including flu-like illness), unexplained fever, scabies and leishmania - Others: asthma, accidents/injuries
Guidelines	Medical center and dispensaries based surveillance guideline: Ar, En
Reporting form	Weekly reporting form
Results	- Latest weekly national bulletin

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B05CX01	DEXTROSE	G	Dextrose, H2O - 10g/100ml	10g/100ml	Injectable solution	220,643 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 20g/100ml	20g/100ml	Injectable solution	369,209 L.L
B05CX01	DEXTROSE 20% INJECTION USP	G	Glucose - 20%	20%	Injectable solution	316,025 L.L
B05CX01	DEXTROSE 20% INJECTION USP	G	Glucose - 20%	20%	Injectable solution	183,869 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	174,062 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	174,062 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	170,630 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	182,720 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	205,933 L.L
B05CX01	DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	193,062 L.L
B05CX01	DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
B05CX01	DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	158,587 L.L
B05CX01	DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	158,587 L.L
B05CX01	DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
B05CX01	DEXTROSE INJECTION 5%	G	Dextrose, H2O - 5g/100ml		Injectable solution	212,797 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	188,772 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	188,772 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	195,361 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	224,565 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	185,340 L.L
L02AE04	DECAPEPTYL LP	B	Triptorelin (pamoate) - 3mg	3mg	Injectable powder for suspension+diluent	11,778,312 L.L
L02AE04	DECAPEPTYL LP	B	Triptorelin (pamoate) - 11.25mg	11.25mg	Injectable powder for suspension+diluent	31,761,098 L.L
M03AX01	DYSPORT	BioTech	Clostridium botulinum type A neurotoxin complex - 300units	300units	Injectable powder for solution	14,625,182 L.L
M03AX01	DYSPORT	BioTech	Clostridium botulinum type A neurotoxin complex - 500units	500units	Injectable powder for solution	42,726,155 L.L
L01AX04	DACARBAZINE MEDAC	G	Dacarbazine - 200mg	200mg	Injectable powder for solution	15,866,076 L.L
L01AX04	DACARBAZINE MEDAC	G	Dacarbazine - 1,000mg	1,000mg	Injectable powder for solution	5,411,654 L.L
B03BA51	DEPOVEX	B	Aluminium monostearate - 20mg/ml, Cyanocobalamine - 1mg/ml		Injectable oily suspension	423,310 L.L
N03AG01	DEPAKINE	B	Sodium Valproate - 400mg	400mg	Injectable lyophilised powder for solution+diluent	450,187 L.L
L02AE04	DECAPEPTYL	B	Triptorelin - 0.1mg	0.1mg	Injectable lyophilised powder for solution+diluent	2,366,507 L.L
L01BC08	DACOGEN	B	Decitabine - 50mg	50mg	Injectable lyophilised powder for solution	82,405,803 L.L